Round Lake Beach, IL, United States of America

Marlon D Cowart

This inventor holds 59 USPTO granted patents and 12 published patent applications, plus 10 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Chemistry (CPC class C07D). Top assignees: Abbott Laboratories Corporation, Abbvie Inc., Abbvie S.a.r.l.. Active years: 1994-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marlon D Cowart. Retrieved from https://idiyas.com/inventor/marlon-d-cowart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 59 (Patent Applications = 12)

% Patents Active = 47.5

CIPO Patents = 10 (Patent Applications = 17)

EPO Patents = 10 (Patent Applications = 18)

Average Co-Inventor Count = 5.4

ph-index = 9

Forward Citations = 365(Granted Patents)

Forward Citations (Not Self Cited) = 316(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Round Lake, IL (US) (2010 - 2013)
Round Lake Bach, IL (US) (2018)
Round Lake Beach, IL (US) (1994 - 2020)

Company Filing History:

37 out of 4,188

Abbott Laboratories Corporation

where one patent can have more than one assignee

Years Active: 1994-2020

Loading Chart...

Areas of Expertise:

N-sulfonylated-Pyrazolo

Heteroaryl Substituted Pyridines

Tyrosine Kinase Inhibitors

Cystic Fibrosis Treatment

Macrocyclic Pyrimidine Derivatives

Histamine-3 Receptor Ligands

Benzothiazole Derivatives

Cyclopropyl Amine Derivatives

Bicyclic-Substituted Amines

Fused Bicyclic Compounds

Pyrimidine Derivatives

Pain Treatment

59 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2020-05-12),

2. 10604515 - Heteroaryl substituted pyridines and methods of use (2020-03-31),

3. 10508113 - Inhibitors of tyrosine kinase 2 mediated signaling (2019-12-17),

4. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2019-04-16),

5. 10138227 - Heteroaryl substituted pyridines and methods of use (2018-11-27),

6. 10130622 - Compounds for treatment of cystic fibrosis (2018-11-20),

7. 10047051 - Substituted pyridines and method of use (2018-08-14),

8. 9969693 - 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use (2018-05-15),

9. 9890158 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2018-02-13),

10. 9840513 - Substituted tricyclics and method of use (2017-12-12),

11. 9796711 - [object Object] (2017-10-24),

12. 9777020 - Furo-3-carboxamide derivatives and methods of use (2017-10-03),

13. 9452986 - 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use (2016-09-27),

14. 9186353 - Treatment of osteoarthritis pain (2015-11-17),

15. 9181275 - Mercaptoamidine derivatives and methods of use (2015-11-10),

Title: Unveiling the Inventive Journey of Marlon D Cowart

Introduction:

Marlon D Cowart, a prolific inventor based in Round Lake Beach, IL (US), has left an indelible mark in the field of pharmaceuticals with his groundbreaking patents. With an impressive portfolio of 59 patents to his credit, Cowart's innovative spirit shines through in each of his creations.

Latest Patents:

Among his latest patents is the revolutionary "N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use," which introduces compounds beneficial in treating diseases like cystic fibrosis, Sjögren's syndrome, and chronic obstructive lung disease. Additionally, his work on "Heteroaryl substituted pyridines and methods of use" showcases his dedication to advancing treatment options for cystic fibrosis patients.

Career Highlights:

Cowart's illustrious career includes stints at esteemed companies such as Abbott Laboratories Corporation and AbbVie Inc. Throughout his professional journey, he has consistently displayed a remarkable aptitude for innovation and a profound understanding of pharmaceutical development.

Collaborations:

Collaborating with talented individuals like Robert J Altenbach and Huaqing Liu has further enriched Cowart's inventive endeavors. Their combined expertise has led to the successful realization of numerous patents and has significantly contributed to the advancement of medical science.

Conclusion:

In conclusion, Marlon D Cowart's relentless pursuit of innovation and his remarkable contributions to the field of pharmaceuticals underscore his status as a pioneering inventor. His patents not only reflect his technical prowess but also highlight his unwavering commitment to improving healthcare outcomes for individuals worldwide.

Profile summary based on public USPTO records.